Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function.
Animals
Carrier Proteins
/ genetics
Cells, Cultured
Extracellular Matrix Proteins
/ genetics
Humans
Integrin beta Chains
/ genetics
Kruppel-Like Factor 4
Low Density Lipoprotein Receptor-Related Protein-6
/ genetics
Male
Mice
Mice, Inbred C57BL
MicroRNAs
/ genetics
Microfilament Proteins
/ genetics
Muscle, Smooth, Vascular
/ cytology
Myocytes, Smooth Muscle
/ metabolism
Protein-Lysine 6-Oxidase
/ genetics
Proto-Oncogene Mas
Proto-Oncogene Proteins c-yes
/ genetics
RNA, Circular
/ genetics
alternative splicing
circular RNA
epigenomics
gene expression
microRNAs
smooth muscle cells
vascular diseases
Journal
Circulation research
ISSN: 1524-4571
Titre abrégé: Circ Res
Pays: United States
ID NLM: 0047103
Informations de publication
Date de publication:
15 02 2019
15 02 2019
Historique:
pubmed:
26
12
2018
medline:
18
12
2019
entrez:
25
12
2018
Statut:
ppublish
Résumé
microRNAs (miRNAs) modulate gene expression by repressing translation of targeted genes. Previous work has established a role for miRNAs in regulating vascular smooth muscle cell (VSMC) activity. Whether circular RNAs are involved in the modulation of miRNA activity in VSMCs is unknown. We aimed to identify circular RNAs interacting with miRNAs enriched in VSMCs and modulating the cells' activity. RNA sequencing and bioinformatics identified several circular RNAs enriched in VSMCs; however, only one, possessing multiple putative binding sites for miR-145, was highly conserved between mouse and man. This circular RNA gemmed from alternative splicing of Lrp6 (lipoprotein receptor 6), a gene highly expressed in vessels and implicated in vascular pathologies and was thus named circ_Lrp6. Its role as a miR-145 sponge was confirmed by determining reciprocal interaction through RNA immunoprecipitation, stimulated emission depletion microscopy, and competitive luciferase assays; functional inhibition of miR-145 was assessed by measuring expression of the target genes ITGβ8 (integrin-β8), FASCIN (fascin actin-bundling protein 1), KLF4 (Kruppel-like factor 4), Yes1 (YES proto-oncogene 1), and Lox (lysyl oxidase). The interaction was preferentially localized to P-bodies, sites of mRNA degradation. Using loss- and gain-of-function approaches, we found that circ_Lrp6 hindered miR-145-mediated regulation of VSMC migration, proliferation, and differentiation. Differential expression of miR-145 and circ_Lrp6 in murine and human vascular diseases suggests that the ratio of circ_Lrp6 bound to miR-145 versus unbound could play a role in vascular pathogenesis. Viral delivery of circ_Lrp6 shRNA prevented intimal hyperplasia in mouse carotids. circ_Lrp6 is an intracellular modulator and a natural sponge for miR-145, counterbalancing the functions of the miRNA in VSMCs.
Identifiants
pubmed: 30582454
doi: 10.1161/CIRCRESAHA.118.314240
doi:
Substances chimiques
Carrier Proteins
0
Extracellular Matrix Proteins
0
Integrin beta Chains
0
KLF4 protein, human
0
Klf4 protein, mouse
0
Kruppel-Like Factor 4
0
Low Density Lipoprotein Receptor-Related Protein-6
0
Lrp6 protein, mouse
0
MAS1 protein, human
0
MIRN145a microRNA, mouse
0
MicroRNAs
0
Microfilament Proteins
0
Proto-Oncogene Mas
0
RNA, Circular
0
integrin beta8
0
fascin
146808-54-0
Lox protein, mouse
149137-54-2
Protein-Lysine 6-Oxidase
EC 1.4.3.13
Proto-Oncogene Proteins c-yes
EC 2.7.10.2
Yes1 protein, mouse
EC 2.7.10.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
498-510Commentaires et corrections
Type : CommentIn